Medtronic PLC settled for $50.9 million to resolve claims related to the marketing of medical devices and for allegedly engaging in kickback schemes, The New York Times reports. As part of the agreement, ev3 Inc.- which Medtronic owns- plead guilty to marketing a neurovascular medical device for unproven and dangerous uses. A whistleblower, former employee Jeffrey Faatz, brought forth the investigation under the qui tam provision of the False Claims Act. For his part of the investigation, he will receive a $2.02 million reward.
A doctor for a Chicago surgical center was convicted of health care fraud for billing insurance companies $3.5 million in operations that never occurred. Between 2005-2009, he ordered his staff to bill insurers for surgical procedures that were never actually performed, and he submitted claims with falsified patients’ names, addresses and birthdays. He faces up to 79 years in prison. To read more from NBC 5 Chicago, click here.
LivaNova USA, Inc. has agreed to pay $1.87 million to resolve allegations it violated the False Claims Act by knowingly paying kickbacks to Georgia physicians with intent to cause referrals for implantation of LivaNova’s medical devices. The allegations were brought forth by Ashley Case, a former employee, under the whistleblower provisions of the False Claims Act. To read more from the Department of Justice press release, click here.
To learn more about our Whistleblower & Qui Tam practice click here. Our firm is located in Nashville, Tennessee but we represent whistleblowers all around the country. Call us today at (615) 244-2202.